GoodRx Holdings, Inc. (GDRX) |
|
6.565 0.145 (2.26%)
|
03-24 12:33 |
|
Open: |
6.33 |
Pre. Close: |
6.42 |
|
High:
|
6.62 |
Low:
|
6.33 |
|
Volume:
|
502,641 |
Market Cap:
|
2,708(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 12:01:16 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 8.1 One year: 9.46 |
| Support: |
Support1: 5.81 Support2: 5.11 |
| Resistance: |
Resistance1: 6.94 Resistance2: 8.1 |
| Pivot: |
6.17  |
| Moving Average: |
MA(5): 6.54 MA(20): 6
MA(100): 5.27 MA(250): 7.03  |
| MACD: |
MACD(12,26): 0.3 Signal(9): 0.2 |
| Stochastic oscillator: |
%K(14,3): 75 %D(3): 80.8 |
| RSI: |
RSI(14): 64.5 |
| 52-week: |
High: 20.59 Low: 3.81 |
| Average Vol(K): |
3-Month: 1,748 (K) 10-Days: 2,105 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GDRX ] has closed below upper band by 26.9%. Bollinger Bands are 47.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.74 - 6.78 |
6.78 - 6.81 |
|
Low:
|
6.26 - 6.3 |
6.3 - 6.34 |
|
Close:
|
6.36 - 6.43 |
6.43 - 6.49 |
|
Company Description |
|
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California. |
Headline News |
Fri, 24 Mar 2023
GoodRx Holdings Inc. (NASDAQ: GDRX):The Stock Was Up 40.5 ... - Marketing Sentinel
Thu, 23 Mar 2023
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation? - Simply Wall St
Wed, 22 Mar 2023
GoodRx Holdings Inc. (GDRX) Stock: Navigating the Market Volatility - The News Heater
Mon, 13 Mar 2023
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of ... - MarketBeat
Fri, 10 Mar 2023
Vanguard Group Now Owns 10.09% of GoodRx Holdings, Inc. (GDRX) - Nasdaq
Fri, 03 Mar 2023
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2022 Earnings Call Transcript - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Health Information Services |
| Shares Out. |
84 (M) |
| Shares Float |
79 (M) |
|
% Held by Insiders
|
6.1 (%) |
|
% Held by Institutions
|
62.7 (%) |
|
Shares Short
|
13,000 (K) |
|
Shares Short P.Month
|
11,990 (K) |
Stock Financials |
|
EPS
|
-0.08 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
2.04 |
|
Profit Margin (%)
|
-4.3 |
|
Operating Margin (%)
|
5.1 |
|
Return on Assets (ttm)
|
1.5 |
|
Return on Equity (ttm)
|
-4 |
|
Qtrly Rev. Growth
|
-13.7 |
|
Gross Profit (p.s.)
|
8.36 |
|
Sales Per Share
|
9.14 |
|
EBITDA (p.s.)
|
0.8 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
147 (M) |
|
Levered Free Cash Flow
|
108 (M) |
Stock Valuations |
|
PE Ratio
|
-82.44 |
|
PEG Ratio
|
12.3 |
|
Price to Book value
|
3.21 |
|
Price to Sales
|
0.72 |
|
Price to Cash Flow
|
3.76 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
